Liver cirrhosis trials in Japan

In Japan 6 Also abroad 360

6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Where
Bunkyō-Ku, Fukui-shi, Kyoto, Maebashi, Minato-Ku, Musashino, Nagasaki, Ōgaki, Saga, Sakai, Shinjuku, Suita-shi, Tsu, Wakayama, Yokohama
Age
18 years to 80 years
People
2,150 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06528314
Phase 3Taking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Bunkyō City, Chiba, Ehime, Toon, Fukui-shi, Fukuoka, Fukuoka, Fukuoka, Kurume, Gifu, Gifu, Gifu, Ogaki, Hanishina-gun, Hiroshima, Hokkaido, Sapporo, Ibaraki, Inashiki-gun, Isehara-Shi, Ishikawa, Kanazawa, Izumo, Kagoshima, Kanagawa, Kawasaki, Kita-gun, Kobe, Kumamoto, Kure, Kyoto, Miyazaki, Musashino, Nagano, Matsumoto, Nagasaki, Omura, Nara, Kashihara, Narita, Niigata, Nishinomiya, Ōita, Okayama, Osaka, Saga, Sakai, Sapporo, Sendai, Shiwa-gun, Shizuoka, Hamamatsu, Shizuoka, Izunokuni, Suita-shi, Suita-Shi, Takasaki-shi, Tokyo, Tokyo, Bunkyo-ku, Tokyo, Minato-ku, Toyoake-shi, Tsu, Wakayama, Yokohama
Age
18 years and over
People
1,590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
Phase 3Taking people
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Where
Kawasaki-shi, Ōgaki
Age
18 years to 75 years
People
1,740 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07701993
Phase 3Taking people
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Where
Kawasaki-shi, Ōgaki
Age
18 years to 75 years
People
380 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07704892
Phase 2Taking people
A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
Where
Bunkyo Ku, Osaka, Sapporo, Sendai
Age
18 years to 79 years
People
7
Run by
Kiminori Kimura, MD
See details and how to joinNCT07681089
No phaseTaking people
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
Where
Fukuoka, Hiroshima, Kyoto, Nagasaki, Tokyo
Age
18 years to 80 years
People
3,000 worldwide
Run by
European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921